Profiel
Baron Jean Stphenne is een Belgisch zakenman die aan het hoofd heeft gestaan van 23 verschillende ondernemingen. Momenteel is hij Voorzitter van Nanocyl SA, Voorzitter van Parc d'aventures scientifiques SCRL, Voorzitter van Bone Therapeutics SA, Voorzitter van BePharBel Manufacturing SA, Voorzitter van OncoDNA SA, Voorzitter van Innoste SA, Voorzitter van de Raad van Toezicht van CureVac NV, Voorzitter van de Raad van Toezicht van CureVac AG (een dochteronderneming van CureVac NV), Voorzitter & Chief Executive Officer van Recherche Et Industrie Therapeutiques, Voorzitter van TiGenix NV en Voorzitter van Vesalius Biocapital II SA SICAR. Hij is tevens Voorzitter van de Universitaire Stichting en Voorzitter van de Universit Catholique de Louvain en zetelt in de raad van bestuur van 6 andere vennootschappen. Baron Jean Stphenne was voorheen Voorzitter van Ion Beam Applications SA, Voorzitter & President van Gsk Biologicals, President van Union Wallonne des Entreprises, Voorzitter & President van GlaxoSmithKline Biologicals SA, Voorzitter van Aseptic Technologies NV, Voorzitter van Vesalius Biocapital I SA SICAR, Voorzitter van het Wallon Institute for Life Lead Sciences en Voorzitter van BioWin ASBL. De heer Stphenne behaalde een bachelordiploma aan de Universit Catholique de Louvain en een bachelordiploma aan de Facult Universitaire des Sciences Agronomiques de Gembloux.
Actieve functies van Baron Jean Stéphenne
| Bedrijven | Functie | Begin |
|---|---|---|
| CUREVAC | Voorzitter | 01-08-2015 |
Recherche Et Industrie Therapeutiques | Algemeen Directeur | 01-01-1974 |
Nanocyl SA
Nanocyl SA SteelNon-Energy Minerals Specializes in manufacturing of industrial multiwall carbon nanotubes | Voorzitter | 01-01-2012 |
BePharBel Manufacturing SA
BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Voorzitter | - |
University Foundation
University Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Voorzitter | - |
Vesalius Biocapital II SA SICAR
Vesalius Biocapital II SA SICAR Investment ManagersFinance Acts as Venture Capital Fund | Voorzitter | - |
Innoste SA | Voorzitter | - |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Voorzitter | 02-04-2020 |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Voorzitter | - |
| ░░░░░░░░░ ░░░░░ ░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Eerdere bekende functies van Baron Jean Stéphenne
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Opleiding van Baron Jean Stéphenne
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 36 |
|---|---|
Ion Beam Applications SA
Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Groupe Bruxelles Lambert SA
Groupe Bruxelles Lambert SA Financial ConglomeratesFinance Operates as holding company whose subsidiaries which provides investment, diagnostics and outpatient, business process outsourcing & manufactures bicycles | Finance |
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
IntegraGen SA
IntegraGen SA Medical/Nursing ServicesHealth Services Develops cutting edge genome analysis products | Health Services |
BNP Paribas Fortis SA/NV
BNP Paribas Fortis SA/NV Major BanksFinance Provides international banking services | Finance |
Faculté Universitaire des Sciences Agronomiques de Gembloux
Faculté Universitaire des Sciences Agronomiques de Gembloux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aseptic Technologies SA
Aseptic Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures aseptic production equipment, isolator & robot lines | Health Technology |
Henogen SA
Henogen SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals | Health Technology |
Nanocyl SA
Nanocyl SA SteelNon-Energy Minerals Specializes in manufacturing of industrial multiwall carbon nanotubes | Non-Energy Minerals |
N-Side SA
N-Side SA Miscellaneous Commercial ServicesCommercial Services engages in management consulting services | Commercial Services |
Vesalius Biocapital I SA SICAR
Vesalius Biocapital I SA SICAR Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Opus-Invest NV
Opus-Invest NV Construction MaterialsNon-Energy Minerals Engages in construction of prefabrication concrete elements, electricity supply and building renovation services | Non-Energy Minerals |
Union Wallonne des Entreprises
Union Wallonne des Entreprises Miscellaneous Commercial ServicesCommercial Services Operates as a business associations | Commercial Services |
Federation of Enterprises in Belgium
Federation of Enterprises in Belgium Miscellaneous Commercial ServicesCommercial Services Represents companies in all the three regions of belgium | Commercial Services |
BESIX Group NV
BESIX Group NV Engineering & ConstructionIndustrial Services Provides buildings, infrastructure construction, property development and concessions services | Industrial Services |
Sparkoh CV
Sparkoh CV Real Estate DevelopmentFinance Operates a scientific convention center | Finance |
Auguria Residential Real Estate Fund (Brussels) | |
Bone Therapeutics SA
Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops regenerative therapy products for addressing unmet medical needs in the field of bone diseases and orthopedics | Health Technology |
Wallon Institute for Life Lead Sciences | |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers | Commercial Services |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Electronic Technology |
Vesalius Biocapital II SA SICAR
Vesalius Biocapital II SA SICAR Investment ManagersFinance Acts as Venture Capital Fund | Finance |
University Foundation
University Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Theravectys SAS
Theravectys SAS BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
BePharBel Manufacturing SA
BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Fondation Belge Contre Le Cancer | |
OncoDNA SA
OncoDNA SA Medical/Nursing ServicesHealth Services Develops and provides diagnosic and analytical tools for cancer treatment | Health Services |
Innoste SA | |
Vaxxilon AG
Vaxxilon AG BiotechnologyHealth Technology Develops and manufactures novel synthetic vaccines | Health Technology |
Gsk Biologicals
Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products | Commercial Services |
Belgian Foundation Against Cancer | |
CureVac NV
CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Recherche Et Industrie Therapeutiques |
















